Open AccessBlood glucose changes surrounding initiation of tumor-necrosis factor inhibitors and conventional disease-modifying anti-rheumatic drugs in veterans with rheumatoid arthritis
Author(s) -
Patrick Wood,
Evan Manning,
Joshua F. Baker,
Bryant R. England,
Lisa Davis,
Grant W. Can,
Ted R. Mikuls,
Liron Caplan
Publication year - 2018
Publication title -
world journal of diabetes
Language(s) - English
Resource type - Journals
ISSN - 1948-9358
DOI - 10.4239/wjd.v9.i2.53
Subject(s) - medicine , hydroxychloroquine , sulfasalazine , rheumatoid arthritis , antirheumatic agents , tumor necrosis factor alpha , disease , rheumatoid factor , rheumatic disease , necrosis , tumor necrosis factor α , immunology , covid-19 , ulcerative colitis , infectious disease (medical specialty)
To determine the scope of acute hypoglycemic effects for certain anti-rheumatic medications in a large retrospective observational study.